$1.14
0.005000.44%
At close: -
$1.14
0.000.00%
After Hours: 4:02 PM EDT
Comments
Loading...
Repare Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:RPTX | Benzinga
Repare Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-0.720
Quarterly Revenue Estimate
$2.34M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$53.48M
Analyze the earnings history of Repare Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RPTX | Repare Therapeutics | $0.30 | -$0.72 | — | — | $52.40M | $2.34M | — | — | 05/06/2025 | Get Alert |
| RPTX | Repare Therapeutics | -$0.67 | -$0.79 | -$0.67 | 15.19% | $13.05M | $2.73M | $0.00 | -100.00% | 03/03/2025 | Get Alert |
| RPTX | Repare Therapeutics | -$0.45 | -$0.87 | -$0.81 | 6.90% | $2.16M | $2.91M | $0.00 | -100.00% | 11/07/2024 | Get Alert |
| RPTX | Repare Therapeutics | -$0.28 | -$0.87 | -$0.82 | 5.75% | $30.25M | $2.92M | $1.07M | -63.30% | 08/06/2024 | Get Alert |
| RPTX | Repare Therapeutics | -$0.83 | $0.02 | $0.30 | 1400.00% | $5.68M | $38.40M | $52.40M | 36.47% | 05/07/2024 | Get Alert |
| RPTX | Repare Therapeutics | -$0.75 | -$0.46 | -$0.67 | -45.65% | $18.20M | $18.93M | $13.05M | -31.08% | 02/28/2024 | Get Alert |
| RPTX | Repare Therapeutics | $1.71 | -$0.86 | -$0.45 | 47.67% | $112.55M | $6.31M | $2.16M | -65.78% | 11/09/2023 | Get Alert |
| RPTX | Repare Therapeutics | -$0.91 | -$0.78 | -$0.28 | 64.10% | $679.00K | $7.68M | $30.25M | 293.87% | 08/09/2023 | Get Alert |
| RPTX | Repare Therapeutics | -$0.83 | -$0.81 | -$0.83 | -2.47% | $408.00K | $6.12M | $5.68M | -7.22% | 05/09/2023 | Get Alert |
| RPTX | Repare Therapeutics | -$0.70 | -$0.97 | -$0.75 | 22.68% | $6.88M | $10.83M | $18.20M | 68.03% | 02/28/2023 | Get Alert |
| RPTX | Repare Therapeutics | -$0.83 | -$0.89 | $1.71 | 292.13% | $278.00K | $1.58M | $112.55M | 7023.10% | 11/09/2022 | Get Alert |
| RPTX | Repare Therapeutics | -$0.71 | -$0.86 | -$0.91 | -5.81% | $279.00K | — | $679.00K | — | 08/04/2022 | Get Alert |
| RPTX | Repare Therapeutics | -$0.58 | -$0.86 | -$0.83 | 3.49% | $166.00K | $2.35M | $408.00K | -82.64% | 05/05/2022 | Get Alert |
| RPTX | Repare Therapeutics | -$0.41 | -$0.74 | -$0.70 | 5.41% | $135.00K | $3.28M | $6.88M | 109.66% | 03/01/2022 | Get Alert |
| RPTX | Repare Therapeutics | -$0.37 | — | -$0.83 | — | $0.00 | — | $278.00K | — | 11/10/2021 | Get Alert |
| RPTX | Repare Therapeutics | -$2.45 | -$0.60 | -$0.71 | -18.33% | $0.00 | $600.00K | $279.00K | -53.50% | 08/12/2021 | Get Alert |
| RPTX | Repare Therapeutics | — | -$0.58 | -$0.58 | 0.00% | — | $620.00K | $166.00K | -73.23% | 05/13/2021 | Get Alert |
| RPTX | Repare Therapeutics | -$5.45 | — | -$0.41 | — | — | — | $135.00K | — | 03/04/2021 | Get Alert |
| RPTX | Repare Therapeutics | -$5.03 | — | -$0.37 | — | — | — | $0.00 | — | 11/11/2020 | Get Alert |
| RPTX | Repare Therapeutics | -$4.16 | — | -$2.45 | — | — | — | $0.00 | — | 08/13/2020 | Get Alert |
Repare Therapeutics (RPTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $-0.67 | $-0.79 | 15.2 % |
| Q3 | 2024-11-07 | $-0.81 | $-0.87 | 6.90 % |
| Q2 | 2024-08-06 | $-0.82 | $-0.87 | 5.75 % |
| Q1 | 2024-05-07 | $0.30 | $0.02 | 1400.0 % |
Repare Therapeutics (RPTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $0 | $2.73M | -100.0 % |
| Q3 | 2024-11-07 | $0 | $2.91M | -100.0 % |
| Q2 | 2024-08-06 | $1.07M | $2.92M | -63.3 % |
| Q1 | 2024-05-07 | $52.40M | $38.40M | 36.5 % |
FAQ
When is Repare Therapeutics (NASDAQ:RPTX) reporting earnings?
Repare Therapeutics (RPTX) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on March 3, 2025 for Q4.
What were the latest earnings per share (EPS) for Repare Therapeutics (NASDAQ:RPTX)?
The Actual EPS was $-0.67, which beat the estimate of $-0.79.
What were Repare Therapeutics’s (NASDAQ:RPTX) revenues?
The Actual Revenue was $0K, which missed the estimate of $2.7M.
Browse earnings estimates, EPS, and revenue on all stocks.